The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Open accessAbstract
Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally. It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage destruction and bone erosion. While until the 1990s RA frequently resulted in disability, inability to work, and increased mortality, newer treatment options have made RA a manageable disease. Here, great progress has been made in the development of disease-modifying anti-rheumatic drugs (DMARDs) which target inflammation and thereby prevent further joint damage. The available DMARDs are subdivided into (1) conventional synthetic DMARDs (methotrexate, hydrochloroquine, and sulfadiazine), (2) targeted synthetic DMARDs (pan-JAK- and JAK1/2-inhibitors), and (3) biologic DMARDs (tumor necrosis factor (TNF)-α inhibitors, TNF-receptor (R) inhibitors, IL-6 inhibitors, IL-6R inhibitors, B cell depleting antibodies, and inhibitors of co-stimulatory molecules). While DMARDs have repeatedly demonstrated the potential to greatly improve disease symptoms and prevent disease progression in RA patients, they are associated with considerable side-effects and high financial costs. This review summarizes our current understanding of the underlying pathomechanism, diagnosis of RA, as well as the mode of action, clinical benefits, and side-effects of the currently available DMARDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,941
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Diagnosis and Management of Rheumatoid Arthritis: A Review
Aletaha, D., & Smolen, J. S. (2018) · JAMA · doi:10.1001/jama.2018.13103 · Cited by 2,313
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., & Dazzi, F. (2003) · Blood · doi:10.1182/blood-2002-07-2104 · Cited by 1,598
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Neutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“IL-17A produced by Th17 cells promotes both the production of the pro-inflammatory cytokines IL-6, IL-8, and GM-CSF from epithelial, endothelial, and fibroblastic cells [68] and neutrophil recruitment [69], which leads to local inflammation and promotes disease progression.”
BackgroundGoekoop‐Ruiterman, Y. P. M., De Vries‐Bouwstra, J. K., Allaart, C. F., Van Zeben, D., Kerstens, P. J. S. M., Hazes, J. M. W., Zwinderman, A. H., Ronday, H. K., Han, K. H., Westedt, M. L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21405 · Cited by 1,460
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
Komatsu, N., Okamoto, K., Sawa, S., Nakashima, T., Oh-hora, M., Kodama, T., Tanaka, S., Bluestone, J. A., & Takayanagi, H. (2014) · Nature Medicine · doi:10.1038/nm.3432 · Cited by 1,153
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
Novel treatment strategies in rheumatoid arthritis
Burmester, G. R., & Pope, J. E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31491-5 · Cited by 1,068
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
New therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., Saigo, K., Morinobu, A., Koshiba, M., Kuntz, K. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00008 · Cited by 873
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Taylor, P. C., Keystone, E. C., van der Heijde, D., Weinblatt, M. E., del Carmen Morales, L., Reyes Gonzaga, J., Yakushin, S., Ishii, T., Emoto, K., Beattie, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608345 · Cited by 872
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
T-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Pettit, A. R., Ji, H., von Stechow, D., Müller, R., Goldring, S. R., Choi, Y., Benoist, C., & Gravallese, E. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63016-7 · Cited by 807
Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007
Myasoedova, E., Crowson, C. S., Kremers, H. M., Therneau, T. M., & Gabriel, S. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27425 · Cited by 802
Nishimoto, N., Terao, K., Mima, T., Nakahara, H., Takagi, N., & Kakehi, T. (2008) · Blood · doi:10.1182/blood-2008-05-155846 · Cited by 795
Alamanos, Y., Voulgari, P. V., & Drosos, A. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.08.006 · Cited by 782
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., & Kudo, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4858 · Cited by 731
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0109-2 · Cited by 719
Synovial fibroblasts spread rheumatoid arthritis to unaffected joints
Lefèvre, S., Knedla, A., Tennie, C., Kampmann, A., Wunrau, C., Dinser, R., Korb, A., Schnäker, E.-M., Tarner, I. H., Robbins, P. D., et al. (2009) · Nature Medicine · doi:10.1038/nm.2050 · Cited by 717
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Wegner, N., Wait, R., Sroka, A., Eick, S., Nguyen, K., Lundberg, K., Kinloch, A., Culshaw, S., Potempa, J., & Venables, P. J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27552 · Cited by 683
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V., & Amigorena, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.018 · Cited by 676
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
Genetic and environmental risk factors for rheumatoid arthritis
Deane, K. D., Demoruelle, M. K., Kelmenson, L. B., Kuhn, K. A., Norris, J. M., & Holers, V. M. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.08.003 · Cited by 666
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
Pescovitz, M. D. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01288.x · Cited by 625
van de Putte, L. B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Bijlsma, J. W., Todesco, S., Dougados, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013052 · Cited by 617
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 590
Epidemiology of rheumatic diseases
Sangha, O. (2000) · Rheumatology · doi:10.1093/rheumatology/39.suppl_2.3 · Cited by 575
Calabró, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566
Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.997 · Cited by 561
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
The pathogenic role of angiogenesis in rheumatoid arthritis
Elshabrawy, H. A., Chen, Z., Volin, M. V., Ravella, S., Virupannavar, S., & Shahrara, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9477-2 · Cited by 533
Charles, P. J., Elliott, M. J., Davis, D., Potter, A. R., Kalden, J. R., Antoni, C., Breedveld, F. C., Js, S., Eberl, G., DeWoody, K. L., et al. (1999) · PubMed · Cited by 531
JAK inhibitors in dermatology: The promise of a new drug class
Damsky, W., & King, B. A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.005 · Cited by 530
Nie, H., Zheng, Y., Li, R., Guo, T. B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3085 · Cited by 515
Nadkarni, S., Mauri, C., & Ehrenstein, M. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061531 · Cited by 507
Furst, D. E., Schiff, M. H., Fleischmann, R., Strand, V., Birbara, C. A., Compagnone, D., Fischkoff, S. A., & Chartash, E. (2003) · PubMed · Cited by 495
van Everdingen, A. A., Jacobs, J. W. G., Siewertsz van Reesema, D. R., & Bijlsma, J. W. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00006 · Cited by 489
Reboul, P., Pelletier, J. P., Tardif, G., Cloutier, J. M., & Martel-Pelletier, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118636 · Cited by 487
Yap, H.-Y., Tee, S. Z.-Y., Wong, M. M.-T., Chow, S.-K., Peh, S.-C., & Teow, S.-Y. (2018) · Cells · doi:10.3390/cells7100161 · Cited by 486
Schmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Rituximab: A Review of its Use in Non-Hodgkin??s Lymphoma and Chronic Lymphocytic Leukaemia
Plosker, G. L., & Figgitt, D. P. (2003) · Drugs · doi:10.2165/00003495-200363080-00005 · Cited by 471
Wegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmström, V., Feldmann, M., & Venables, P. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00850.x · Cited by 471
New insights into the use of currently available non-steroidal anti-inflammatory drugs
Brune, & Patrignani, P. (2015) · Journal of Pain Research · doi:10.2147/jpr.s75160 · Cited by 469
Up‐regulation of cytokines and chemokines predates the onset of rheumatoid arthritis
Kokkonen, H., Söderström, I., Rocklöv, J., Hallmans, G., Lejon, K., & Rantapää Dahlqvist, S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27186 · Cited by 454
Forslind, K., Ahlmén, M., Eberhardt, K., Hafström, I., & Svensson, B. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014233 · Cited by 445
Strategies toward rheumatoid arthritis therapy; the old and the new
Abbasi, M., Mousavi, M. J., Jamalzehi, S., Alimohammadi, R., Bezvan, M. H., Mohammadi, H., & Aslani, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27860 · Cited by 443
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
van Schouwenburg, P. A., Rispens, T., & Wolbink, G. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.4 · Cited by 438
Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1521 · Cited by 436
Mechanism of action of hydroxychloroquine as an antirheumatic drug
Fox, R. I. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(10)80012-5 · Cited by 430
Tocilizumab: A review in rheumatoid arthritis
Scott, L. J. (2017) · Drugs · doi:10.1007/s40265-017-0829-7 · Cited by 419
Mariette, X., Matucci-Cerinic, M., Pavelka, K., Taylor, P., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., & Emery, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.149419 · Cited by 404
Mariette, X., Förger, F., Abraham, B., Flynn, A. D., Moltó, A., Flipo, R.-M., van Tubergen, A., Shaughnessy, L., Simpson, J., Teil, M., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212196 · Cited by 404
Van Ede, A. E., Laan, R. F. J. M., Rood, M. J., Huizinga, T. W. J., Van De Laar, M. A. F. J., Denderen, C. J. V., Westgeest, T. A. A., Romme, T. C., De Rooij, D.-J. R. A. M., Jacobs, M. J. M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7 · Cited by 401
Cohen, S. B., Tanaka, Y., Mariette, X., Curtis, J. R., Lee, E. B., Nash, P., Winthrop, K. L., Charles-Schoeman, C., Thirunavukkarasu, K., DeMasi, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210457 · Cited by 393
The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Moreland, L. W., O'Dell, J. R., Paulus, H. E., Curtis, J. R., Bathon, J. M., St.Clair, E. W., Bridges, S. L., Zhang, J., McVie, T., Howard, G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34498 · Cited by 389
Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
Krishna, M., & Nadler, S. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00021 · Cited by 389
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
O'Dell, J. R., Mikuls, T. R., Taylor, T. H., Ahluwalia, V., Brophy, M., Warren, S. R., Lew, R. A., Cannella, A. C., Kunkel, G., Phibbs, C. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303006 · Cited by 382
McGraw, W. T., Potempa, J., Farley, D., & Travis, J. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3248-3256.1999 · Cited by 378 · cited 3×
“While the association between periodontitis and RA development was recognized as early as the 19th century [11], recent studies have demonstrated that infections with the common periodontal bacterium Porphyromonas gingivalis can result in the induction of autoimmune responses via the citrullination of host peptides [2…”
BackgroundRecommendations on screening for chloroquine and hydroxychloroquine retinopathy
Marmor, M. F., Carr, R. E., Easterbrook, M., Farjo, A. A., & Mieler, W. F. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01168-5 · Cited by 371
Baker, K. F., & Isaacs, J. D. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211555 · Cited by 370
Leombruno, J. P., Einarson, T. R., & Keystone, E. C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091025 · Cited by 362
Smolen, J. S., Nash, P., Durez, P., Hall, S., Ilivanova, E., Irazoque-Palazuelos, F., Miranda, P., Park, M.-C., Pavelka, K., Pedersen, R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61811-x · Cited by 357
Rheumatoid Factors: Clinical Applications
Ingegnoli, F., Castelli, R., & Gualtierotti, R. (2013) · Disease Markers · doi:10.1155/2013/726598 · Cited by 351
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22579 · Cited by 348
Westhovens, R., Robles, M., Ximenes, A. C., Nayiager, S., Wollenhaupt, J., Durez, P., Gomez-Reino, J., Grassi, W., Haraoui, B., Shergy, W., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101121 · Cited by 348
Krishnamurthy, A., Joshua, V., Haj Hensvold, A., Jin, T., Sun, M., Vivar, N., Ytterberg, A. J., Engström, M., Fernandes-Cerqueira, C., Amara, K., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208093 · Cited by 348
De Rycke, L., Peene, I., Hoffman, I. E. A., Kruithof, E., Union, A., Meheus, L., Lebeer, K., Wyns, B., Vincent, C., Mielants, H., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017574 · Cited by 341
Chabaud, M., Lubberts, E., Joosten, L., van den Berg, W., & Miossec, P. (2001) · Arthritis Research & Therapy · doi:10.1186/ar294 · Cited by 333
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Hvas, C. L., Bibby, B. M., Uldbjerg, N., Connell, W. R., Rosella, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.002 · Cited by 328
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Pfeifle, R., Rothe, T., Ipseiz, N., Scherer, H. U., Culemann, S., Harre, U., Ackermann, J. A., Seefried, M., Kleyer, A., Uderhardt, S., et al. (2017) · Nature Immunology · doi:10.1038/ni.3579 · Cited by 321
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Early Diagnosis and Treatment of Rheumatoid Arthritis
Littlejohn, E. A., & Monrad, S. U. (2018) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2018.02.010 · Cited by 315
STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6
Zhang, D., Sun, M., Samols, D., & Kushner, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9503 · Cited by 309
The Many Alternative Faces of Macrophage Activation
Hume, D. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00370 · Cited by 308
Calabro, P., Chang, D. W., Willerson, J. T., & Yeh, E. T. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.017 · Cited by 308
Wassenberg, S., Rau, R., Steinfeld, P., Zeidler, H., & Low‐Dose Prednisolone Therapy Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21421 · Cited by 308
Askling, J., Fahrbach, K., Nordstrom, B., Ross, S., Schmid, C. H., & Symmons, D. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2046 · Cited by 301
Structural recognition and functional activation of FcγR by innate pentraxins
Lu, J., Marnell, L. L., Marjon, K. D., Mold, C., Du Clos, T. W., & Sun, P. D. (2008) · Nature · doi:10.1038/nature07468 · Cited by 301
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 296
Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics
Rajagopalan, P. T. R., Zhang, Z., McCourt, L., Dwyer, M., Benkovic, S. J., & Hammes, G. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172501499 · Cited by 295
Gerlag, D. M., Safy, M., Maijer, K. I., Tang, M. W., Tas, S. W., Starmans-Kool, M. J. F., van Tubergen, A., Janssen, M., de Hair, M., Hansson, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212763 · Cited by 295
Schiff, M., Weinblatt, M. E., Valente, R., van der Heijde, D., Citera, G., Elegbe, A., Maldonado, M., & Fleischmann, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203843 · Cited by 293
Rombouts, Y., Ewing, E., van de Stadt, L. A., Selman, M. H. J., Trouw, L. A., Deelder, A. M., Huizinga, T. W. J., Wuhrer, M., van Schaardenburg, D., Toes, R. E. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203565 · Cited by 288
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
Guo, C., Fu, R., Wang, S., Huang, Y., Li, X., Zhou, M., Zhao, J., & Yang, N. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13167 · Cited by 285
Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278
CONTRIBUTION OF INTERLEUKIN 17 TO SYNOVIUM MATRIX DESTRUCTION IN RHEUMATOID ARTHRITIS
Chabaud, M., Garnero, P., Dayer, J.-M., Guerne, P.-A., Fossiez, F., & Miossec, P. (2000) · Cytokine · doi:10.1006/cyto.2000.0681 · Cited by 277
Increased Frequency of Circulating Follicular Helper T Cells in Patients with Rheumatoid Arthritis
Ma, J., Zhu, C., Ma, B., Tian, J., Baidoo, S. E., Mao, C., Wu, W., Chen, J., Tong, J., Yang, M., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/827480 · Cited by 263
Xu, W. D., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis
Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbander, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24827 · Cited by 253
Ercan, A., Cui, J., Chatterton, D. E. W., Deane, K. D., Hazen, M. M., Brintnell, W., O'Donnell, C. I., Derber, L. A., Weinblatt, M. E., Shadick, N. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27533 · Cited by 245
TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
Marahleh, A., Kitaura, H., Ohori, F., Kishikawa, A., Ogawa, S., Shen, W.-R., Qi, J., Noguchi, T., Nara, Y., & Mizoguchi, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02925 · Cited by 244
Emery, P. E., Burmester, G. R., Bykerk, V. P., Combe, B. G., Fürst, D. E., Barré, E., Karyekar, C. S., Wong, D. A., & Huizinga, T. W. J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206106 · Cited by 241
Chemin, K., Gerstner, C., & Malmström, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00353 · Cited by 237
Leeuwen, M. A. V., van der Heijde, D. M. F. M., van Rijswijk, M. H., Houtman, P. M., van Riel, P. L. C. M., van de Putte, L. B. A., & Limburg, P. C. (1994) · PubMed · Cited by 236
Felson, D. T., Anderson, J. J., & Meenan, R. F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351003 · Cited by 230
van Vollenhoven, R. F., Geborek, P., Forslind, K., Albertsson, K., Ernestam, S., Petersson, I. F., Chatzidionysiou, K., & Bratt, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60027-0 · Cited by 228
Cytokine production by synovial T cells in rheumatoid arthritis
Steiner, G. (1999) · Rheumatology · doi:10.1093/rheumatology/38.3.202 · Cited by 228
Sulfasalazine: A Review of its Use in the Management of Rheumatoid Arthritis
Plosker, G. L., & Croom, K. F. (2005) · Drugs · doi:10.2165/00003495-200565130-00008 · Cited by 226
Scherer, H. U., van der Woude, D., Ioan‐Facsinay, A., el Bannoudi, H., Trouw, L. A., Wang, J., Häupl, T., Burmester, G., Deelder, A. M., Huizinga, T. W. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27414 · Cited by 223
Huizinga, T. W. J., Fleischmann, R. M., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, X., Yancopoulos, G. D., Stahl, N., & Genovese, M. C. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204405 · Cited by 222
Page, G., Lebecque, S., & Miossec, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5333 · Cited by 220
Functional subsets of CD4 T cells in rheumatoid synovitis
Namekawa, T., Wagner, U. G., Goronzy, J. J., & Weyand, C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2108::aid-art5>3.0.co;2-q · Cited by 220
Genovese, M. C., Fleischmann, R., Kivitz, A. J., Rell‐Bakalarska, M., Martincova, R., Fiore, S., Rohane, P., van Hoogstraten, H., Garg, A., Fan, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39093 · Cited by 219
Work disability in rheumatoid arthritis 10 years after the diagnosis.
Sokka, T., Kautiainen, H., Möttönen, T. T., & Hannonen, P. (1999) · PubMed · Cited by 216
Regional analysis of p53 mutations in rheumatoid arthritis synovium
Yamanishi, Y., Boyle, D. L., Rosengren, S., Green, D. R., Zvaifler, N. J., & Firestein, G. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152333199 · Cited by 214
IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review
Ogata, A., Kato, Y., Higa, S., & Yoshizaki, K. (2019) · Modern Rheumatology · doi:10.1080/14397595.2018.1546357 · Cited by 211
C-reactive protein in rheumatology: biology and genetics
Rhodes, B., Fürnrohr, B. G., & Vyse, T. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.37 · Cited by 207
Apoptosis in rheumatoid arthritis
Baier, A., Meineckel, I., Gay, S., & Pap, T. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00015 · Cited by 207
Predictors of radiographic joint damage in patients with early rheumatoid arthritis
Jansen, L. M. A., van der Horst-Bruinsma, I. E., van Schaardenburg, D., Bezemer, P. D., & Dijkmans, B. A. C. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.10.924 · Cited by 205
Jongbloed, S. L., Lebre, M. C., Fraser, A. R., Gracie, J. A., Sturrock, R. D., Tak, P. P., & McInnes, I. B. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1864 · Cited by 204
Wolfe, F. (1997) · PubMed · Cited by 202
Apoptosis in rheumatoid arthritis
Tak, P. P., & Firestein, G. S. (1999) · Apoptosis and Inflammation · doi:10.1007/978-3-0348-8741-0_9 · Cited by 200
Abatacept: A Review in Rheumatoid Arthritis
Blair, H. A., & Deeks, E. D. (2017) · Drugs · doi:10.1007/s40265-017-0775-4 · Cited by 199
Wang, J., Shan, Y., Jiang, Z., Feng, J., Li, C., Ma, L., & Jiang, Y. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12162 · Cited by 196
Lenz, T. L., Deutsch, A. J., Han, B., Hu, X., Okada, Y., Eyre, S., Knapp, M., Zhernakova, A., Huizinga, T. W. J., Abecasis, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3379 · Cited by 195
Han, K. H., Hong, K.-H., Park, J.-H., Ko, J., Kang, D.-H., Choi, K.-J., Hong, M.-K., Park, S.-W., & Park, S.-J. (2004) · Circulation · doi:10.1161/01.cir.0000131160.94926.6e · Cited by 192
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis
Goh, F. G., & Midwood, K. S. (2012) · Rheumatology · doi:10.1093/rheumatology/ker257 · Cited by 192
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
Yeo, L., Toellner, K.-M., Salmon, M., Filer, A., Buckley, C. D., Raza, K., & Scheel-Toellner, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.153312 · Cited by 191
Role of neutrophils in systemic autoimmune diseases
Kaplan, M. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4325 · Cited by 191
Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., & Hamilton, J. A. (2001) · Arthritis Research & Therapy · doi:10.1186/ar318 · Cited by 186
IL-17 Contributes to Angiogenesis in Rheumatoid Arthritis
Pickens, S. R., Volin, M. V., Mandelin, A. M., Kolls, J. K., Pope, R. M., & Shahrara, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903271 · Cited by 186
Phillips, D. C., Woollard, K. J., & Griffiths, H. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705054 · Cited by 183
Radner, H., Neogi, T., Smolen, J. S., & Aletaha, D. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203284 · Cited by 183
Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.
Finbloom, D. S., Silver, K., Newsome, D. A., & Gunkel, R. D. (1985) · PubMed · Cited by 180
Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes
Borden, P., Solymar, D., Sucharczuk, A., Lindman, B., Cannon, P., & Heller, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23577 · Cited by 178
Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
Taylor, P. C. (2019) · Rheumatology · doi:10.1093/rheumatology/key225 · Cited by 175
Bos, W. H., Dijkmans, B. A. C., Boers, M., van de Stadt, R. J., & van Schaardenburg, D. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105767 · Cited by 174
Treatment with Biologicals in Rheumatoid Arthritis: An Overview
Rein, P., & Mueller, R. B. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0073-3 · Cited by 174
Gastrointestinal and liver adverse effects of drugs used for treating IBD
Rogler, G. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.10.011 · Cited by 170
Hepatotoxicity related to antirheumatic drugs
Aithal, G. P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.214 · Cited by 170
Complement in the Initiation and Evolution of Rheumatoid Arthritis
Holers, V. M., & Banda, N. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01057 · Cited by 168
Lebre, M. C., Jongbloed, S. L., Tas, S. W., Smeets, T. J. M., McInnes, I. B., & Tak, P. P. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070703 · Cited by 167
Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
Jung, S. M., Kim, K., Yang, C. W., Park, S., & Ju, J. H. (2014) · Journal of Immunology Research · doi:10.1155/2014/263625 · Cited by 167
Rheumatoid arthritis and smoking: putting the pieces together
Baka, Z., Buzás, E., & Nagy, G. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2751 · Cited by 166
Nam, J. L., Villeneuve, É., Hensor, E. M. A., Conaghan, P. G., Keen, H. I., Buch, M. H., Gough, A., Green, M. J., Helliwell, P., Keenan, A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203440 · Cited by 166
Devlin, J., Gough, A., Huissoon, A. P., Perkins, P., Holder, R. L., Reece, R., Arthur, V., & Emery, P. (1997) · PubMed · Cited by 166
Robert, M., & Miossec, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2018.00364 · Cited by 165
Ramwadhdoebé, T. H., van Baarsen, L. G. M., Boumans, M. J. H., Bruijnen, S. T. G., Safy‐Khan, M., Berger, F. H., Semmelink, J. F., van der Laken, C. J., Gerlag, D. M., Thurlings, R. M., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key428 · Cited by 163
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Burmester, G. R., Weinblatt, M. E., McInnes, I. B., Porter, D. R., Барбараш, О. Л., Vatutin, M. T., Szombati, I., Esfandiari, E., Sleeman, M. A., Kane, C. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202450 · Cited by 161
Human Leukocyte Antigen–Disease Associations in Rheumatoid Arthritis
van Drongelen, V., & Holoshitz, J. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.04.003 · Cited by 160
Mallya, R. K., de Beer, F. C., Berry, H., et al. (1982) · PubMed · Cited by 159
Interferon-Gamma-Mediated Osteoimmunology
Tang, M., Tian, L., Luo, G., & Yu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01508 · Cited by 159
Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines
Kim, E. Y., & Moudgil, K. D. (2017) · Cytokine · doi:10.1016/j.cyto.2017.04.012 · Cited by 157
Zheng, Z., Li, X. Y., Ding, J., Jia, J., & Zhu, P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem284 · Cited by 155
Microbial Infection and Rheumatoid Arthritis
Yue, Y. Y. Y. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000174 · Cited by 153
On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid
Sousa, T., Yadav, V., Zann, V., Borde, A., Abrahamsson, B., & Basit, A. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24103 · Cited by 151
Park, E. H., Lim, H.-S., Lee, S., Roh, K.-H., Seo, K., Kang, K., & Shin, K. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0031 · Cited by 144
Methotrexate in rheumatoid arthritis: a quarter century of development.
Weinblatt, M. E. (2013) · PubMed · Cited by 142
Morita, Y., Yamamura, M., Kawashima, M., Harada, S., Tsuji, K., Shibuya, K., Maruyama, K., & Makino, H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1669::aid-art19>3.0.co;2-g · Cited by 142
Kwak, H. B., Ha, H., Kim, H., Lee, J.-H., Kim, H. S., Lee, S., Kim, H., Kim, J. Y., Kim, H., Song, Y. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23372 · Cited by 141
Machold, K. P., Landewé, R., Smolen, J. S., Stamm, T., van der Heijde, D. M. F. M., Verpoort, K. N., Brickmann, K., Vázquez‐Mellado, J., Karateev, D. E., Breedveld, F. C., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122473 · Cited by 139
Smolen, J. S., Weinblatt, M. E., Sheng, S., Zhuang, Y., & Hsu, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205137 · Cited by 139
Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis
Azizi, G., Jadidi‐Niaragh, F., & Mirshafiey, A. (2013) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12132 · Cited by 138
Kyburz, D., Brentano, F., & Gay, S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0292 · Cited by 136
TNF-α blockade induces IL-10 expression in human CD4+ T cells
Evans, H. G., Roostalu, U., Walter, G. J., Gullick, N., Frederiksen, K. S., Roberts, C. A., Sumner, J., Baeten, D., Gerwien, J. G., Cope, A. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4199 · Cited by 134
C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes.
Kuta, A. E., & Baum, L. L. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.1.321 · Cited by 132
Burmester, G. R., McInnes, I. B., Kremer, J. M., Miranda, P., Korkosz, M., Vencovský, J., Rubbert‐Roth, A., Mysler, E., Sleeman, M. A., Godwood, A., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210624 · Cited by 132
Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles
Coutant, F., & Miossec, P. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.147 · Cited by 131
Ghoryani, M., Shariati‐Sarabi, Z., Tavakkol‐Afshari, J., Ghasemi, A., Poursamimi, J., & Mohammadi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.056 · Cited by 128
Wang, T., Sun, X., Zhao, J., Zhang, J., Zhu, H., Li, C., Gao, N., Yuan, J., Xu, D., Huang, F., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204228 · Cited by 126
Pharmacotherapy Options in Rheumatoid Arthritis
Kumar, P., & Banik, S. (2013) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.4137/cmamd.s5558 · Cited by 125
Verstappen, S. M. M., McCoy, M. J., Roberts, C., Dale, N., HASSELL, A. B., & Symmons, D. P. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119149 · Cited by 125
Cascão, R., Moura, R. A., Perpetuo, I. P., Canhão, H. M., Vieira‐Sousa, E., Mourão, A. F., Rodrigues, A. M., Pereira, J. P., Queiroz, M. V., Rosario, H., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3168 · Cited by 124
Siegel, J. N., Osmand, A. P., Wilson, M. F., & Gewurz, H. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.3.709 · Cited by 124
Korswagen, L.-A., Bartelds, G. M., Krieckaert, C. L. M., Turkstra, F., Nurmohamed, M. T., van Schaardenburg, D., Wijbrandts, C. A., Tak, P. P., Lems, W. F., Dijkmans, B. A. C., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30209 · Cited by 121
Regulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 119
Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
Amari, W., Zeringue, A., McDonald, J. R., Caplan, L., Eisen, S. A., & Ranganathan, P. (2011) · Rheumatology · doi:10.1093/rheumatology/ker113 · Cited by 119
Nandakumar, K. S., Collin, M., Olsén, A., Nimmerjahn, F., Blom, A. M., Ravetch, J. V., & Holmdahl, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200737581 · Cited by 118
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Tavakolpour, S., Alesaeidi, ., Darvishi, M., Ghasemiadl, M., Darabi-Monadi, S., Akhlaghdoust, M., Behjati, S. E., & Jafarieh, A. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04699-8 · Cited by 117
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
Maxwell, L. J., & Singh, J. A. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091066 · Cited by 115
Cited by
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Chronic tissue inflammation and metabolic disease
Lee, Y. S., & Olefsky, J. (2021) · Genes & Development · doi:10.1101/gad.346312.120 · Cited by 335
Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis
Wang, Y., Chen, S., Du, K., Liang, C., Wang, S., Owusu Boadi, E., Li, J., Pang, X., He, J., & Chang, Y.-X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114368 · Cited by 264
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment
Wu, D., Luo, Y., Li, T., Zhao, X., Lv, T., Fang, G., Ou, P., Li, H., Luo, X., Huang, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051082 · Cited by 263
Metadata
- Authors
- Lin, Y.-J., Anzaghe, M., & Schülke, S.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-04-03
- Volume
- 9
- Issue
- 4
- Pages
- 880
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3014146563
- Cited by
- 932
- References
- 276
- FWCI
- 69.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.